Differential effect of CLK SR Kinases on HIV-1 gene expression: potential novel targets for therapy
Open Access
- 17 June 2011
- journal article
- research article
- Published by Springer Nature in Retrovirology
- Vol. 8 (1) , 1-12
Abstract
Background: RNA processing plays a critical role in the replication of HIV-1, regulated in part through the action of host SR proteins. To explore the impact of modulating SR protein activity on virus replication, the effect of increasing or inhibiting the activity of the Cdc2-like kinase (CLK) family of SR protein kinases on HIV-1 expression and RNA processing was examined. Results: Despite their high homology, increasing individual CLK expression had distinct effects on HIV-1, CLK1 enhancing Gag production while CLK2 inhibited the virus. Parallel studies on the anti-HIV-1 activity of CLK inhibitors revealed a similar discrepant effect on HIV-1 expression. TG003, an inhibitor of CLK1, 2 and 4, had no effect on viral Gag synthesis while chlorhexidine, a CLK2, 3 and 4 inhibitor, blocked virus production. Chlorhexidine treatment altered viral RNA processing, decreasing levels of unspliced and single spliced viral RNAs, and reduced Rev accumulation. Subsequent experiments in the context of HIV-1 replication in PBMCs confirmed the capacity of chlorhexidine to suppress virus replication. Conclusions: Together, these findings establish that HIV-1 RNA processing can be targeted to suppress virus replication as demonstrated by manipulating individual CLK function and identified chlorhexidine as a lead compound in the development of novel anti-viral therapies.Keywords
This publication has 57 references indexed in Scilit:
- Rapid-Response Splicing Reporter Screens Identify Differential Regulators of Constitutive and Alternative SplicingMolecular and Cellular Biology, 2010
- Cdc2-like Kinase 2 Is an Insulin-Regulated Suppressor of Hepatic GluconeogenesisCell Metabolism, 2010
- Kinase Domain Insertions Define Distinct Roles of CLK Kinases in SR Protein PhosphorylationStructure, 2009
- Role of Cellular RNA Processing Factors in Human Immunodeficiency Virus Type 1 mRNA Metabolism, Replication, and InfectivityJournal of Virology, 2009
- Modulating HIV-1 RNA processing and utilizationFrontiers in Bioscience-Landmark, 2008
- HIV drug development: the next 25 yearsNature Reviews Drug Discovery, 2007
- Utilization of host SR protein kinases and RNA-splicing machinery during viral replicationProceedings of the National Academy of Sciences, 2006
- Manipulation of Alternative Splicing by a Newly Developed Inhibitor of ClksJournal of Biological Chemistry, 2004
- hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structureRNA, 2002
- Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cellsJournal of Immunological Methods, 1992